346 related articles for article (PubMed ID: 27685104)
21. Dosimetric optimization of a colpostat in a 60Co high-dose-rate brachytherapy unit for bladder sparing.
Zakariaee SS; Mahdavi SR
Brachytherapy; 2015; 14(1):37-45. PubMed ID: 25260688
[TBL] [Abstract][Full Text] [Related]
22. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236
[TBL] [Abstract][Full Text] [Related]
23. OUT-OF-FIELD DOSES IN CHILDREN TREATED FOR LARGE ARTERIOVENOUS MALFORMATIONS USING HYPOFRACTIONATED GAMMA KNIFE RADIOSURGERY AND INTENSITY-MODULATED RADIATION THERAPY.
De Saint-Hubert M; Majer M; Hršak H; Heinrich Z; Kneževic Ž; Miljanic S; Porwol P; Stolarczyk L; Vanhavere F; Harrison RM
Radiat Prot Dosimetry; 2018 Oct; 181(2):100-110. PubMed ID: 29351691
[TBL] [Abstract][Full Text] [Related]
24. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
Phys Med; 2018 Sep; 53():129-136. PubMed ID: 30241747
[TBL] [Abstract][Full Text] [Related]
25. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
27. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
28. Doses to internal organs for various breast radiation techniques--implications on the risk of secondary cancers and cardiomyopathy.
Pignol JP; Keller BM; Ravi A
Radiat Oncol; 2011 Jan; 6():5. PubMed ID: 21235766
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of surface and shallow depth dose reductions using a Superflab bolus during conventional and advanced external beam radiotherapy.
Yoon J; Xie Y; Zhang R
J Appl Clin Med Phys; 2018 Mar; 19(2):137-143. PubMed ID: 29427312
[TBL] [Abstract][Full Text] [Related]
30. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
Mostafa L; Rachid K; Ahmed SM
Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of organ doses in brachytherapy treatment of uterus cancer using mathematical reference Indian adult phantom.
Biju K
Radiat Prot Dosimetry; 2012 Jan; 148(2):185-8. PubMed ID: 21343234
[TBL] [Abstract][Full Text] [Related]
32. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
Mille MM; Xu XG; Rivard MJ
Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
[TBL] [Abstract][Full Text] [Related]
33. Calculating and estimating second cancer risk from breast radiotherapy using Monte Carlo code with internal body scatter for each out-of-field organ.
Takata T; Shiraishi K; Kumagai S; Arai N; Kobayashi T; Oba H; Okamoto T; Kotoku J
J Appl Clin Med Phys; 2020 Dec; 21(12):62-73. PubMed ID: 33128332
[TBL] [Abstract][Full Text] [Related]
34. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of various approaches for assessing dose indicators and patient organ doses resulting from radiotherapy cone-beam CT.
Rampado O; Giglioli FR; Rossetti V; Fiandra C; Ragona R; Ropolo R
Med Phys; 2016 May; 43(5):2515. PubMed ID: 27147362
[TBL] [Abstract][Full Text] [Related]
36. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
37. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
38. Absorbed dose calculations in a brachytherapy pelvic phantom using the Monte Carlo method.
Rodríguez ML; deAlmeida CE
J Appl Clin Med Phys; 2002; 3(4):285-92. PubMed ID: 12383048
[TBL] [Abstract][Full Text] [Related]
39. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
Bednarz B; Hancox C; Xu XG
Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
[TBL] [Abstract][Full Text] [Related]
40. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
